Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Hepatology
•
Liver Tumors
How do you counsel patients experiencing symptoms/complications of menopause who desire use of HRT if they have a history of known hepatic adenomas?
Related Questions
What is your (institutional) approach to treatment options (ex: SBRT, chemotherapy) in liver transplant protocols for control of unresectable hepatic colorectal metastases while awaiting transplant?
How does the identification of a hepatic adenoma in a male patient affect your management and evaluation?
What patient factors impact your selection of initial therapies in patients with localized cholangiocarcinoma?
How do you foresee the integration of artificial intelligence in the management and evaluation of patients with liver lesions/tumors?
What prognostic models have been developed to predict HCC risk in HCV patients post-SVR?
What pre-transplant patient factors impact surveillance intervals and methods after liver transplant for HCC?
How do you approach treatment options for patients with fibrolamellar HCC compared to "normal" HCC?
How does the use of checkpoint inhibitors for treatment of HCC impact timing of liver transplant and subsequent immunosuppression?
What clinical features would raise your suspicion for IgG-4 related disease?
How has the GALAD score affected your practice for HCC screening?
